In 2023, Glaukos Corporation, a prominent company specializing in innovative treatments for glaucoma, corneal disorders and retinal diseases, achieved approval from the FDA for iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog designed for a single administration per eye. It ...
Kobelt, G, Jonsson, L (1999) Modeling cost of treatment with new topical treatments for glaucoma: results from France and the United Kingdom. Int J Technol Assess Health Care 15: pp. 207-219Kobelt, G, Jonsson, L (1999) Modeling cost of treatment with new topical treatments for glaucoma:...
Researchers have developed a tool to not only model the underlying disease mechanisms of glaucoma, but also to help discover and test new pharmacological strategies to combat the neurodegeneration that occurs in patients with glaucoma. Investigators designed a method that allowed them to take patient-d...
The latest glaucoma treatments, news, information and insights from multi-awarded Glaucoma Surgeon in California, Dr. David Richardson. A Glaucoma HealthHub designed to provide answers to commonly asked questions about glaucoma, care and treatment option
an increase in intraocular pressure can damage the optic nerve, leading to vision loss. The precise mechanism of elevated resistance to aqueous humor outflow remains unclear, and although the current treatments for glaucoma tackle the production and outflow of aqueous humor, their outcomes are still...
During the seminar, Professor Ge discussed unconventional treatments such as brain-computer interface, stem cell therapy, and gene editing for restoring vision, particularly in advanced glaucoma cases. He mentioned that artificial visual devices could be a promising solution for addressing late-stage glau...
During the seminar, Professor Ge discussed unconventional treatments such as brain-computer interface, stem cell therapy, and gene editing for restoring vision, particularly in advanced glaucoma cases. He mentioned that artificial visual devices could be a promising solution for addressing late-stage glau...
During the seminar, Professor Ge discussed unconventional treatments such as brain-computer interface, stem cell therapy, and gene editing for restoring vision, particularly in advanced glaucoma cases. He mentioned that artificial visual devices could be a promising solution for addressing late-stage glau...
The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol 2002; 86(5): 551-554.Bateman DN, Clark R, Azuara-Blanco A, et al. The effects of new topical treatments on management of glaucoma in Scotland: an ...
meshwork, which is located at the front of the eye. The lesser pathway is through the SCS, which normally has only a very small gap. In glaucoma, the dominant pathway is blocked, so to lessen pressure, treatments are created to open the lesser pathway enough to let the aqueous humor ...